BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 26462888)

  • 1. [Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells].
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):251-7. PubMed ID: 26462888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
    Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
    Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity to chemotherapeutic drugs of polyploid tumor cells induced by a spindle poison nocodazole].
    Hao J; Yuan BB; Xu YF; Yu J; Liu GY; Wang DH
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):419-24. PubMed ID: 22967442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of siRNA-mediated down-regulation of CD147 on human breast cancer cells].
    Li Z; Li D; Li J; Huang P; Qin H
    Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):734-8. PubMed ID: 26702532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of down-regulation of CC chemokine ligand 5 (CCL5) on proliferation of human breast cancer cells in vitro].
    Kuang JX; Wang WX; Sun SR; Wang WR; Yao XL
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):174-7. PubMed ID: 21575514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.
    Park SY; Kim MJ; Park SA; Kim JS; Min KN; Kim DK; Lim W; Nam JS; Sheen YY
    Oncotarget; 2015 Nov; 6(35):37526-43. PubMed ID: 26462028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of transcription factor Oct4 induces an epithelial-to-mesenchymal transition via enhancement of Ca2+ influx in breast cancer cells.
    Hu J; Qin K; Zhang Y; Gong J; Li N; Lv D; Xiang R; Tan X
    Biochem Biophys Res Commun; 2011 Aug; 411(4):786-91. PubMed ID: 21798248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Down-regulation of Smoothened gene expression inhibits proliferation of breast cancer stem cells].
    Mao J; Fan PH; Ma W; Zhang QQ; Wang B; Fan SJ; Li LH
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):262-6. PubMed ID: 23928535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of osteopontin expression by RNA interference affects cell proliferation and chemotherapy sensitivity of breast cancer MDA-MB-231 cells.
    Yang L; Wei L; Zhao W; Wang X; Zheng G; Zheng M; Song X; Zuo W
    Mol Med Rep; 2012 Feb; 5(2):373-6. PubMed ID: 22143930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Astragalus polysaccharide on proliferation and Akt phosphorylation of the basal-like breast cancer cell line].
    Ye MN; Chen HF; Zhou RJ; Liao MJ
    Zhong Xi Yi Jie He Xue Bao; 2011 Dec; 9(12):1339-46. PubMed ID: 22152773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
    Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
    Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of biological function on ovarian clear cell carcinoma ES2 cell line with ARID1A gene expression down-regulating in vitro].
    Lyu CS; Zhang YL; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):209-15. PubMed ID: 27030501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Knockdown of CART1 induces S phase arrest and inhibits invasion and migration of MDA-MB-231 breast cancer cells].
    Guan T; Su L; Yi Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):474-8. PubMed ID: 27053613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of mammalian-target-of-rapamycin pathway on lapatinib resistance in breast cancer MDA-MB-231 cells].
    Wang JD; Wang QS; Bai YZ; Kou DQ; Li XR; Chen L; Li R
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1915-7. PubMed ID: 24124748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on RNA interference silencing hMSH2 induces the reversal chemo-resistance of ovarian carcinoma cell line OC3/TAX300].
    Wang A; Li J; Li H
    Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):213-7. PubMed ID: 24820308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiangiogenic drugs enhance the ability of invasion and metastasis of breast cancer cells under serum starvation and hypoxia].
    Wei L; Cuicui Z; Jing W; Kai L
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):244-50. PubMed ID: 26462887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
    Mao J; Song B; Shi Y; Wang B; Fan S; Yu X; Tang J; Li L
    Int J Biochem Cell Biol; 2013 Jun; 45(6):1064-73. PubMed ID: 23500524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dendritic cells infected by recombinant adeno-associated virus with CEA gene to induce antigen-specific CTL response to CD44(+)CD24(-/low) cells from MCF-7 breast cancer cell line].
    Wang XL; Ma B; Jia J; Yuan YH; Yan Y; Di LJ; Song GH; Yu J; Ren J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):173-8. PubMed ID: 21503107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.